Perlmutter, Jane

Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP Guideline update

Allison, K. H., Hammond, M. E. H., Dowsett, M., McKernin, S. E., Carey, L. A., Fitzgibbons, P. L., Hayes, D. F., Lakhani, S. R., Chavez-MacGregor, M., Perlmutter, J., et al. (2020) · Journal of Clinical Oncology

Breast Cancer Treatment StudiesBreast Lesions and Carcinomas

Cited by 1,574

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial

Nanda, R., Liu, M. C., Yau, C., Shatsky, R., Pusztai, L., Wallace, A., Chien, A. J., Forero-Torres, A., Ellis, E., Han, H., et al. (2020) · JAMA Oncology

Breast Cancer Treatment StudiesCancer Treatment and Pharmacology

Cited by 710

Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial

Basch, E., Schrag, D., Henson, S., Jansen, J., Ginos, B., Stover, A. M., Carr, P., Spears, P. A., Jonsson, M., Deal, A. M., et al. (2022) · JAMA

Cancer survivorship and careMobile Health and mHealth Applications

Cited by 413

Current Landscape of Immunotherapy in Breast Cancer: A Review

Adams, S., Gatti-Mays, M. E., Kalinsky, K., Korde, L. A., Sharon, E., Amiri-Kordestani, L., Bear, H., McArthur, H. L., Frank, E., Perlmutter, J., et al. (2019) · JAMA Oncology

Cancer Immunotherapy and BiomarkersBreast Cancer Treatment Studies

Cited by 384

Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative

Calis, K. A., Archdeacon, P., Bain, R., DeMets, D., Donohue, M., Elzarrad, M. K., Forrest, A., McEachern, J., Pencina, M. J., Perlmutter, J., et al. (2017) · Clinical Trials

Statistical Methods in Clinical TrialsEthics in Clinical Research

Cited by 58